biotech / news / / TNW
Helical, a London-based pharma AI startup, has raised $10 million in a seed round.
Helical’s AI platform is already deployed in production with multiple top-20 global pharma companies.
KEY POINTS
- Their Virtual Lab and Model Factory share data, enabling reproducible, consistent pharma research across disciplines.
- Helical's partnership with Pfizer focuses on predictive blood-based safety biomarkers using AI.
- Teams using Helical’s platform have reduced drug discovery timelines from years to weeks.
- The seed round included Cohere and HuggingFace CEOs as angel investors.
COMPANIES
Summarized by Newsio from TNW. How we summarize →